PubMed

Identification and management of diabetic nephropathy in the diabetes clinic.

Craig KJ, Donovan K, Munnery M, Owens DR, Williams JD, Phillips AO.

Diabetes Care. 2003 Jun;26(6):1806-11.PMID: 12766114 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetic nephropathy: common questions.

Thorp ML.

Am Fam Physician. 2005 Jul 1;72(1):96-9. Review.PMID: 16035688 [PubMed - indexed for MEDLINE]Related articles

Prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type 2 diabetes: an Asian perspective.

Pan CY, Ho LT, Soegondo S, Prodjosudjadi W, Suwanwalaikorn S, Lim SC, Chan TM, Chow KW, Thoenes M, Choi DS; DEMAND Study Investigators.

Diabetes Technol Ther. 2008 Oct;10(5):397-403.PMID: 18715217 [PubMed - indexed for MEDLINE]Related articles

Effect of ACE and AT-2 inhibitors on mortality and progression to microalbuminuria in a nested case-control study of diabetic nephropathy in diabetes mellitus type 2: results from the GENDIAN study.

Böger CA, Haak T, Götz AK, Christ J, Ruff E, Hoffmann U, Riegger GA, Krämer BK.

Int J Clin Pharmacol Ther. 2006 Aug;44(8):364-74.PMID: 16961167 [PubMed - indexed for MEDLINE]Related articles

Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy.

Sato A, Tabata M, Hayashi K, Saruta T.

Clin Exp Nephrol. 2003 Sep;7(3):215-20.PMID: 14586718 [PubMed - indexed for MEDLINE]Related articles

Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45).

Unnikrishnan RI, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R, Mohan V.

Diabetes Care. 2007 Aug;30(8):2019-24. Epub 2007 May 8.PMID: 17488949 [PubMed - indexed for MEDLINE]Related articlesFree article

An aid to the early detection and management of diabetic nephropathy: assessment of a new point of care microalbuminuria system in the diabetic clinic.

Collins AC, Vincent J, Newall RG, Mitchell KM, Viberti GC.

Diabet Med. 2001 Nov;18(11):928-32.PMID: 11703439 [PubMed - indexed for MEDLINE]Related articles

The telmisartan renoprotective study from incipient nephropathy to overt nephropathy--rationale, study design, treatment plan and baseline characteristics of the incipient to overt: angiotensin II receptor blocker, telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study.

Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, Kawamori R, Takeuchi M, Katayama S.

J Int Med Res. 2005 Nov-Dec;33(6):677-86.PMID: 16372586 [PubMed - indexed for MEDLINE]Related articles

Microalbuminuria screening for patients having type 2 diabetes mellitus: who wants to participate?

Leung GM, Redelmeier DA, Szalai JP, Boyle E, Hilditch JR, Tobe SW.

Clin Invest Med. 2001 Feb;24(1):37-43.PMID: 11266030 [PubMed - indexed for MEDLINE]Related articles

Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.

Ruilope LM, Segura J.

Clin Ther. 2003 Dec;25(12):3044-64. Review.PMID: 14749145 [PubMed - indexed for MEDLINE]Related articles

Screening for nephropathy and antiangiotensin use among diabetic patients in an academic community medical center.

Frazee LA, Samandari S, Tanphaichitr N, Bourguet CC, Pfister EW.

Am J Ther. 2006 Jan-Feb;13(1):18-23.PMID: 16428918 [PubMed - indexed for MEDLINE]Related articles

Diabetic nephropathy: an observational study on patients attending a joint diabetes renal clinic.

Liew BS, Perry C, Boulton-Jones JM, Simpson K, Paterson K.

QJM. 1997 May;90(5):353-8.PMID: 9205671 [PubMed - indexed for MEDLINE]Related articlesFree article

The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics.

BENEDICT Group.

Control Clin Trials. 2003 Aug;24(4):442-61.PMID: 12865039 [PubMed - indexed for MEDLINE]Related articles

Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.

Agha A, Bashir K, Anwar E.

Nepal Med Coll J. 2007 Jun;9(2):79-83.PMID: 17899953 [PubMed - indexed for MEDLINE]Related articles

Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.

Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.

Clin Exp Hypertens. 2005 Feb-Apr;27(2-3):129-38.PMID: 15835375 [PubMed - indexed for MEDLINE]Related articles

Treatment of microalbuminuria in patients with type 2 diabetes mellitus.

Jerums G, MacIsaac RJ.

Treat Endocrinol. 2002;1(3):163-73. Review.PMID: 15799209 [PubMed - indexed for MEDLINE]Related articles

High prevalence of chronic kidney disease in population-based patients diagnosed with type 2 diabetes in downtown Shanghai.

Lu B, Song X, Dong X, Yang Y, Zhang Z, Wen J, Li Y, Zhou L, Zhao N, Zhu X, Hu R.

J Diabetes Complications. 2008 Mar-Apr;22(2):96-103.PMID: 18280439 [PubMed - indexed for MEDLINE]Related articles

Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study.

Spijkerman AM, Dekker JM, Nijpels G, Adriaanse MC, Kostense PJ, Ruwaard D, Stehouwer CD, Bouter LM, Heine RJ.

Diabetes Care. 2003 Sep;26(9):2604-8.PMID: 12941726 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of a rapid screening test for microalbuminuria with a spot measurement of urine albumin-creatinine ratio.

Ng WY, Lui KF, Thai AC.

Ann Acad Med Singapore. 2000 Jan;29(1):62-5.PMID: 10748967 [PubMed - indexed for MEDLINE]Related articles

Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).

Ansquer JC, Foucher C, Rattier S, Taskinen MR, Steiner G; DAIS Investigators.

Am J Kidney Dis. 2005 Mar;45(3):485-93.PMID: 15754270 [PubMed - indexed for MEDLINE]Related articles